Massive asthma study launches to map uncontrolled disease across russia

NCT ID NCT06521229

First seen Nov 01, 2025

Summary

This study is not testing a new treatment. Instead, it will gather information from 9,000 adults with uncontrolled asthma at 70 clinics across Russia. Researchers will look at patient backgrounds, lifestyle habits, and current treatments to better understand how the disease affects people in different regions. The goal is to improve future care by learning from real-world data.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNCONTROLLED ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Astrakhan, Russia

  • Research Site

    ACTIVE_NOT_RECRUITING

    Blagoveshchensk, Russia

  • Research Site

    RECRUITING

    Bryansk, Russia

  • Research Site

    RECRUITING

    Chelyabinsk, Russia

  • Research Site

    RECRUITING

    Gatchina, Russia

  • Research Site

    RECRUITING

    Irkutsk, Russia

  • Research Site

    RECRUITING

    Ivanovo, Russia

  • Research Site

    RECRUITING

    Izhevsk, Russia

  • Research Site

    RECRUITING

    Kazan', Russia

  • Research Site

    RECRUITING

    Kemerovo, Russia

  • Research Site

    RECRUITING

    Krasnodar, Russia

  • Research Site

    RECRUITING

    Krasnoyarsk, Russia

  • Research Site

    RECRUITING

    Lipetsk, Russia

  • Research Site

    RECRUITING

    Makhachkala, Russia

  • Research Site

    RECRUITING

    Moscow, Russia

  • Research Site

    RECRUITING

    Murmansk, Russia

  • Research Site

    RECRUITING

    Nal'chik, Russia

  • Research Site

    ACTIVE_NOT_RECRUITING

    Nizhny Novgorod, Russia

  • Research Site

    RECRUITING

    Nizhny Tagil, Russia

  • Research Site

    RECRUITING

    Novokuznetsk, Russia

  • Research Site

    RECRUITING

    Novosibirsk, Russia

  • Research Site

    RECRUITING

    Omsk, Russia

  • Research Site

    ACTIVE_NOT_RECRUITING

    Omsk, Russia

  • Research Site

    RECRUITING

    Orenburg, Russia

  • Research Site

    RECRUITING

    Perm, Russia

  • Research Site

    RECRUITING

    Petrozavodsk, Russia

  • Research Site

    RECRUITING

    Pyatigorsk, Russia

  • Research Site

    RECRUITING

    Rostov-on-Don, Russia

  • Research Site

    RECRUITING

    Ryazan, Russia

  • Research Site

    RECRUITING

    Saint Petersburg, Russia

  • Research Site

    ACTIVE_NOT_RECRUITING

    Saint Petersburg, Russia

  • Research Site

    RECRUITING

    Samara, Russia

  • Research Site

    RECRUITING

    Saratov, Russia

  • Research Site

    WITHDRAWN

    Smolensk, Russia

  • Research Site

    RECRUITING

    Stavropol, Russia

  • Research Site

    RECRUITING

    Surgut, Russia

  • Research Site

    RECRUITING

    Tomsk, Russia

  • Research Site

    RECRUITING

    Tula, Russia

  • Research Site

    RECRUITING

    Ufa, Russia

  • Research Site

    RECRUITING

    Ulan-Ude, Russia

  • Research Site

    RECRUITING

    Verkhnyaya Pyshma, Russia

  • Research Site

    RECRUITING

    Vladimir, Russia

  • Research Site

    RECRUITING

    Vladivostok, Russia

  • Research Site

    RECRUITING

    Voronezh, Russia

  • Research Site

    RECRUITING

    Yaroslavl, Russia

  • Research Site

    RECRUITING

    Yekaterinburg, Russia

  • Research Site

    RECRUITING

    Yuzhno-Sakhalinsk, Russia

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.